About PET Scanners
Cancer is one of the leading causes of death worldwide. According to WHO, in 2012, it accounted for 8.2 million deaths worldwide, of which lung cancer was the cause of 1.59 million deaths. According to the American Cancer Society, as of 2014, there were 430,090 lung cancer survivors in the US. To treat cancer patients, it is necessary to determine the stage, its location, and whether it is affecting the functions of other organs. This necessitates the use of PET scanners to determine treatment and prognosis.
Technavio’s analysts forecast the global pet scanners market to grow at a CAGR of 3.53% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pet scanners market for 2016-2020. To calculate the market size, the report considers the the revenue generated from the sales of equipment such as stand-alone PET, hybrid PET/CT, and hybrid PET/magnetic resonance imaging (MRI) devices.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Pet Scanners Market 2016-2020
Technavio recognizes the following companies as the key players in the global pet scanners market: Cubresa, GE Healthcare, Mediso, Philips Healthcare, Positron, Siemens Healthcare, and Toshiba Medical Systems.
Other Prominent Vendors in the market are: Brain Biosciences, Capintec, CMR Naviscan, Fujifilm Holdings, Mediso Medical Imaging System, Sophie Biosciences, Avid Pharmaceuticals, BC Technical, Mediso Medical Imaging Systems, Mylin Medical, Orbit Medical Technologies, Oxford Instruments Healthcare, Roses Medical & Surgical Supply, and Sanders Medical.
Commenting on the report, an analyst from Technavio’s team said: “The availability of adequate funding for PET scanners will be a key trend for the market growth. In October 2015, the University of California was awarded $15.5 million from the National Institutes of Health (NIH) to build the world’s first total body PET scanner that can track cancer, which can put the nation at the forefront of molecular imaging. In June 2015, the NHS committed $1.33 million to the Royal United Hospital for the purchase of PET/CT scanners. The hospital will invest an additional $1.55 million for the installation of the scanners.”
According to the report, increase in PET scanning for diagnosis of cancer will be a major key driver for market growth. PET and CT scans have become essential diagnostic techniques for diagnosing and treating cancer, as these techniques help physicians evaluate the extent of a disease, determine if the treatment is working, and help detect recurrent tumors. In 2009, the Institute for Health Economics and Management estimated that 350 such scanners were in use in Europe and over 2,000 PET/CT scanners were in use in the US.
Further, the report states that high cost of PET scanners will be a major challenge against the market growth. The high cost of PET equipment negatively affects the rate of adoption of PET scanners. Worldwide, the cost of a PET scan can range anywhere between $3,000 and $6,000, whereas the cost of a CT scan ranges from $1,200 to $3,200. In 2010, the cost of PET scans in Germany ranged anywhere between $885 and $1,000, whereas, in the UK, the cost varied between $1,030 and $2,109.
Cubresa, GE Healthcare, Mediso, Philips Healthcare, Positron, Siemens Healthcare, Toshiba Medical Systems, Brain Biosciences, Capintec, CMR Naviscan, Fujifilm Holdings, Mediso Medical Imaging System, Sophie Biosciences, Avid Pharmaceuticals, BC Technical, Mediso Medical Imaging Systems, Mylin Medical, Orbit Medical Technologies, Oxford Instruments Healthcare, Roses Medical & Surgical Supply, Sanders Medical.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook